Company Filing History:
Years Active: 2013-2017
Title: Akihiro Okano: Innovator in Pharmaceutical Chemistry
Introduction
Akihiro Okano is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 10 patents to his name, Okano's work is recognized for its potential impact on mental and neurodegenerative disorders.
Latest Patents
One of Okano's latest patents involves a pyrazole derivative aimed at creating a pharmaceutical composition for preventing and treating diseases related to PDE10. This invention focuses on compounds that exhibit a PDE10 inhibitory effect, specifically those with a 4-heteroarylpyrazole-5-carboxylic acid amide structure. The patent outlines the compounds, their pharmaceutically acceptable salts, and their solvates, along with the medical uses of these innovative compounds.
Career Highlights
Okano is currently associated with Mochida Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing critical health issues through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Okano has collaborated with notable colleagues, including Muneyoshi Makabe and Munetaka Ohkouchi. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical compounds.
Conclusion
Akihiro Okano's contributions to pharmaceutical chemistry highlight his dedication to innovation and improving health outcomes. His work continues to pave the way for new treatments in the medical field.